Application Note: Optimizing organoid culture: The importance of growth factor bioactivity and reagent consistency
21 September 2020

In this application note, R&D Systems discusses how its recombinant human R-Spondin 1, WnT-3a, and Noggin consistently show high levels of bioactivity and explains how each new lot is tested side-by-side with previous lots to ensure that the new lot displays the same level of bioactivity and purity as previous lots.